pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    betaine hydrochloride
    Cystadane (betaine hydrochloride)
    Homocystinuria Recordati Rare Diseases Inc
  • Phase 2
    betamethasone
    betamethasone
    Keratoconjunctivitis Sicca (Dry Eye) Surface Ophthalmics Inc
  • Marketed
    betamethasone valerate
    Betamethasone Valerate
    Atopic Dermatitis (Atopic Eczema) Perrigo New York Inc
  • Marketed
← prev
page 189 of 271
next →
Pain89
Neurology1
betaxolol hydrochloride
Betaxolol Hydrochloride
Hypertension
KVK-Tech Inc
  • Marketed
    bethanechol chloride
    Bethanechol Chloride
    Neurogenic Bladder Dysfunction Upsher-Smith Laboratories LLC
  • Marketed
    betibeglogene autotemcel
    Zynteglo (betibeglogene autotemcel)
    Beta Thalassaemia Genetix Biotherapeutics Inc
  • pre_registration
    bevacizumab biosimilar
    Jobevne (bevacizumab-awwb)
    Cervical Cancer Shanghai Henlius Biotech Inc
  • Marketed
    bexagliflozin
    Brenzavvy (bexagliflozin)
    Type 2 Diabetes TheracosBio LLC
  • Marketed
    bexarotene
    Targretin (bexarotene)
    Cutaneous T-Cell Lymphoma Bausch Health Americas Inc
  • Phase 3
    bexicaserin
    bexicaserin
    Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Longboard Pharmaceuticals Inc
  • Phase 2
    bexmarilimab
    Clevegen (bexmarilimab [INN])
    Refractory Acute Myeloid Leukemia Faron Pharmaceuticals Oy
  • Phase 2
    bexotegrast
    bexotegrast
    Primary Sclerosing Cholangitis$PLRX PLIANT THERAPEUTICS, INC.
  • Phase 3
    bezisterim
    bezisterim
    Alzheimer's Disease$BIVI BIOVIE INC.
  • Marketed
    bezlotoxumab
    Zinplava (bezlotoxumab)
    Clostridioides difficile Infections (Clostridium difficil… Merck Sharp & Dohme Corp (Inactive)
  • pre_registration
    bezuclastinib
    bezuclastinib
    Gastrointestinal Stromal Tumor (GIST)$COGT Cogent Biosciences, Inc.
  • Marketed
    bicalutamide
    Bicalutamide
    Metastatic Prostate Cancer Northstar Rx LLC
  • Phase 3
    bifikafusp alfa + onfekafusp alfa
    Nidlegy (bifikafusp alfa [INN] + onfekafusp alfa [INN])
    Metastatic Melanoma Philogen SpA
  • Phase 3
    bimatoprost CR
    bimatoprost
    Ocular Hypertension$SGP SpyGlass Pharma, Inc.
  • Marketed
    bimatoprost SR
    Durysta (bimatoprost)
    Ocular Hypertension$ABBV AbbVie Inc.
  • Phase 3
    bimatoprost grenod
    bimatoprost grenod
    Ocular Hypertension Kowa Co Ltd
  • Marketed
    bimekizumab
    Bimzelx (bimekizumab)
    Plaque Psoriasis (Psoriasis Vulgaris) UCB SA
  • Marketed
    binimetinib
    Mektovi (binimetinib)
    Metastatic Melanoma Array BioPharma Inc
  • pre_registration
    binimetinib + encorafenib
    Braftovi + Mektovi (binimetinib + encorafenib)
    Metastatic Colorectal Cancer$PFE PFIZER INC
  • Phase 2
    bintrafusp alfa
    bintrafusp alfa
    Bile Duct Cancer (Cholangiocarcinoma) Merck KGaA
  • Marketed
    birch triterpenes
    Filsuvez (birch triterpenes)
    Epidermolysis Bullosa Chiesi USA Inc
  • Phase 2
    birelentinib
    birelentinib
    Refractory Chronic Lymphocytic Leukemia (CLL) Dizal Pharmaceutical Co Ltd
  • Phase 2
    bisantrene
    Zantrene (bisantrene)
    Refractory Acute Myeloid Leukemia Racura Oncology Ltd
  • Marketed
    bismuth subsalicylate + metronidazole + tetracycline hydrochloride
    Bismuth Subsalicylate + Metronidazole + Tetracycline Hydrochloride
    Duodenal Ulcer Ailex Pharmaceuticals LLC
  • Preclinical
    bisprezatide copper
    Unspecified PharmaTher Holdings Ltd
  • Phase 2
    bitopertin
    bitopertin
    Anemia$IRON Disc Medicine, Inc.